non-Hodgkin lymphoma

Galapagos Surges On An FDA Win For Its Rival To Gilead, Novartis; But There Are Some Caveats
Investors Business Daily
Mon, 08/26/24 - 11:11 am
Galapagos
CAR-T
FDA
non-Hodgkin lymphoma
Gilead Sciences
Novartis
FDA grants IND clearance for Galapagos’ non-Hodgkin lymphoma therapy trial
Clinical Trials Arena
Fri, 08/23/24 - 10:49 am
Galapagos
non-Hodgkin lymphoma
clinical trials
GLPG5101
After FDA setback, MEI, Kyowa confirm phase 2 efficacy with Japanese blood cancer data drop
Fierce Biotech
Fri, 11/18/22 - 10:45 am
Kyowa Kirin
MEI Pharma
zandelisib
clinical trials
non-Hodgkin lymphoma
Precision hails phase 1/2 data as proof it could deliver the first approved off-the-shelf CAR-T
Fierce Biotech
Wed, 06/8/22 - 11:00 pm
Precision Biosciences
CAR-T
gene therapy
gene editing
non-Hodgkin lymphoma
AACR: In redemption of the PI3K drug class, Bayer's Aliqopa leaps ahead of Gilead's Zydelig in lymphoma
Fierce Pharma
Sun, 04/11/21 - 11:36 pm
AACR
Bayer
Aliqopa
non-Hodgkin lymphoma
follicular lymphoma
Zydelig
#ASH20: Loxo and Eli Lilly show off PhI/II data for their BTK inhibitor in mantle cell lymphoma
Endpoints
Sat, 12/5/20 - 11:28 pm
ASH2020
Eli Lilly
clinical trials
LOXO-305
Loxo Oncology
mantle cell lymphoma
non-Hodgkin lymphoma
5 FDA approval decisions to watch in the 4th quarter
BioPharma Dive
Wed, 09/30/20 - 10:45 am
FDA
drug approvals
vaccines
Pfizer
Moderna Therapeutics
COVID-19
Regeneron
EB3
ebola virus
Alkermes
ALKS-3831
schizophrenia
bipolar disorder
Bristol-Myers Squibb
liso-cel
non-Hodgkin lymphoma
roxadustat
FibroGen
chronic kidney disease
Allogene gives first look at an 'off the shelf' cell therapy for lymphoma
BioPharma Dive
Wed, 05/13/20 - 10:35 pm
Allogene
ASCO 2020
cell therapy
non-Hodgkin lymphoma
ALLO-501
ALLO-647
ASH: Roche bispecific delivers for hard-to-treat lymphoma patients failed by CAR-Ts
Fierce Biotech
Mon, 12/9/19 - 09:48 am
Roche
ASH2019
non-Hodgkin lymphoma
mosunetuzumab
Morphosys to take on CAR-Ts in NHL with promising antibody
Pharmaforum
Mon, 05/20/19 - 11:02 pm
MorphoSys
Celgene
Revlimid
non-Hodgkin lymphoma
clinical trials
tafasitamab
Preclinical data on MD Anderson Cancer Center-developed drug offers hope for Imbruvica-resistant mantle cell lymphoma patients
Endpoints
Sun, 05/12/19 - 01:28 pm
Imbruvica
non-Hodgkin lymphoma
mantle cell lymphoma
JNJ
MD Anderson Cancer Center
Potential Cancer "Vaccine" Shows Promise in Early-Stage NHL Trial
BioSpace
Wed, 04/10/19 - 11:28 pm
vaccines
cancer vaccines
Mount Sinai
non-Hodgkin lymphoma
clinical trials
Trovagene Receives Orphan Drug Designation for Onvansertib (PCM-075) for Treatment of Acute Myeloid Leukemia in Europe
CP Wire
Wed, 08/29/18 - 12:42 pm
TrovaGene
Onvansertib
AML
mCRPC
non-Hodgkin lymphoma
triple negative breast cancer
Can Celgene's latest Revlimid win reverse the company's bad-news streak?
Fierce Pharma
Tue, 07/24/18 - 06:00 pm
Celgene
Revlimid
clinical trials
Roche
Rituxan
non-Hodgkin lymphoma